🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsHow far away are we really from an oral option — my results so far Page 2

How far away are we really from an oral option — my results so far

MounjBrad Sun, Aug 4, 2024 at 1:20 PM 17 replies 2,175 viewsPage 2 of 4
KevinCompounds
VIP Member
5,432
18,234
Dec 2023
Nevada
Aug 4, 2024 at 3:08 PM#6
Dr.SurgeonPGH said:
The OASIS programme put 50mg oral in the same territory as 2.4mg injectable — around 15% mean weight loss — but it needed a dose 20 times larger to…

I do not accept that the fasting window is a minor inconvenience. Adherence data on daily orals with timing requirements is consistently worse than weekly injections, and a drug you take imperfectly is a lower dose than the one on the box.

Happy to go further on any of that.

45 15jennifer_SEA, tyler_CSCS, VanRx_Mike and 42 others
Reply Quote Save Share Report
anders_CPH
Senior Member
1,567
7,234
Feb 2024
Copenhagen, DK
Aug 4, 2024 at 3:50 PM#7

One concrete data point for the thread. If you are going to change something, change one thing and give it long enough to express itself. Four weeks is the usual minimum for anything pharmacological on this board, and two weeks of data has told you almost nothing.

44 14MariaRD, AussieAnna, BethLabQueen and 41 others
Reply Quote Save Share Report
Dr.LipidDallas
VIP Member
2,678
14,567
Dec 2023
Dallas, TX
Aug 4, 2024 at 4:32 PM#8
KevinCompounds said:
I do not accept that the fasting window is a minor inconvenience.

Coming at KevinCompounds’s question from a different direction. Take it one variable at a time. Almost every unanswerable question in these threads is unanswerable because three things changed in the same fortnight, and no amount of subsequent argument can untangle them after the fact.

43 13cory_ATX, lori_vegas, Dr.PulmRoch and 40 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
LondonLisa
Member
912
3,456
Mar 2024
London, UK
Aug 4, 2024 at 5:14 PM#9

Following on from KristenIndy — and this may be the naive question:

How much of the oral variability is the SNAC absorption window and how much is dose, because the two get conflated constantly?

Last edited: Aug 4, 2024 at 7:14 PM
42 12JenPlateau, SallyK_inj, CryptoCarl and 39 others
Reply Quote Save Share Report
MounjBrad
Member
278
890
Oct 2024
Kentucky
Aug 4, 2024 at 8:35 PM#10

OP back with an update, since a thread like this is useless without one.

Follow-up: moving the tablet to the moment I wake, before anything else, was the whole fix. The dose never changed.

22 22marco_milano, pam_columbus, nick_SD_fit and 19 others
Reply Quote Save Share Report

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register